Table 1 Clinical features of MN patients coexisting with LECT2 -associated amyloidosis
Article | Case | Sex | Age | Hypertension | DM | Scr (umol/L) | eGFR (mL/min/1.73m2) | Alb(g/L) | UTP (g/24 h) | Serum Anti-PLA2R | renal PLA2R1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Samar M. Said et al. 2014 [9] | 1–2 | / | / | / | / | / | / | / | / | / | / |
CP Larsen et al. 2014 [10] | 3–7 | / | / | / | / | / | / | / | / | / | / |
Dan-yang Li et al 2020 [11] | 8 | F | 74 | Yes | Yes | 118.0 | 39.2 | 26.5 | 11.26 | Pos | ( +) |
Dan-yang Li et al. 2020 [11] | 9 | F | 61 | No | Yes | 76.0 | 73.2 | 22.3 | 2.44 | NA | ( ±) |
Dan-yang Li et al. 2020 [11] | 10 | M | 79 | Yes | No | 541.8 | 7.96 | 24.7 | 7.92 | Pos | (+ +) |
Dan-yang Li et al. 2020 [11] | 11 | F | 61 | Yes | No | 70.2 | 80.5 | 31.4 | 3.89 | NA | ( ±) |
Li Jia et al. 2021 [12] | 12 | F | 44 | Yes | No | Normal | Normal | 30.7 | 3.55 | 5.22RU/ML | (+ + +) |
The present case | 13 | M | 60 | No | No | 79.0 | 93.3 | 15.0 | 12.50 | Pos | (+ +) |